Chemoinformaics analysis of 2-HYDROXYCYCLOPENTADECAN-1-ONE
| Molecular Weight | 240.387 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 15 |
| Exact Molecular Weight | 240.209 | nRing | 1 |
| Solubility: LogS | -0.498 | nHRing | 0 |
| Solubility: LogP | -0.563 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 45.3242 |
| nHD | 1 | BPOL | 28.9578 |
| QED | 0.168 |
| Synth | 4.112 |
| Natural Product Likeliness | 0.942 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.004 |
| HIA | 0.977 |
| CACO-2 | -5.901 |
| MDCK | 0.0000526 |
| BBB | 0.209 |
| PPB | 0.790956 |
| VDSS | 0.677 |
| FU | 0.339648 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.027 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.886 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.01 |
| CL | 0.644 |
| T12 | 0.49 |
| hERG | 0.004 |
| Ames | 0.035 |
| ROA | 0.345 |
| SkinSen | 0.064 |
| Carcinogencity | 0.037 |
| EI | 0.007 |
| Respiratory | 0.169 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.785455 |